New drug switch may ease shakes in transplant patients
NCT ID NCT03769298
First seen Apr 22, 2026 · Last updated Jun 14, 2026 · Updated 14 times
Summary
This study looks at whether switching from a standard anti-rejection drug to a longer-acting version (Envarsus XR) can reduce tremors in people who have had a pancreas-kidney transplant. About 20 adults who have had their transplant between 3 months and 5 years ago and developed tremors afterward will take part. The goal is to see if the new drug helps with shaking and improves quality of life while keeping the transplanted organs working well.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY PANCREAS TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Wisconsin
RECRUITINGMadison, Wisconsin, 53792, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.